Advertisement

Ernährungstherapie einer Hypercholesterolämie bei Typ-2-Diabetes-Patienten

Kernelemente und therapeutische Möglichkeiten
  • Stefan Lorkowski
  • Christine Dawczynski
Leitthema
  • 15 Downloads

Zusammenfassung

Die Verbesserung der Nahrungsfettqualität ist bei Diabetes-Patienten mit einer Hypercholesterolämie ein wesentlicher Baustein der Ernährungsumstellung zum Erhalt der kardiovaskulären Gesundheit und zur Reduktion des kardiovaskulären Risikos. Ebenso wie bei einer isolierten Hypercholesterolämie sollten bei der diabetischen Dyslipoproteinämie die Zufuhr industriell erzeugter Transfettsäuren minimiert sowie der Verzehr gesättigter Fettsäuren zugunsten einer erhöhten Aufnahme von einfach und mehrfach ungesättigten Fettsäuren vermindert werden. Aufgrund des sehr hohen kardiovaskulären Risikos von Betroffenen mit diabetischer Dyslipoproteinämie sowie der meist nichtoptimalen Compliance und unzureichenden Effektivität von Lebensstilmaßnahmen kann eine Ernährungstherapie pharmakologische Maßnahmen allerdings nicht ersetzen.

Schlüsselwörter

Koronare Herzerkrankung Nahrungsfette Ernährungsumstellung Therapieadhärenz und -Compliance Therapeutische Zielwerte 

Nutrition therapy of hypercholesterolemia in patients with type 2 diabetes mellitus

Key elements and treatment options

Abstract

The improvement of the quality of dietary fat is a key element of dietary interventions for people suffering from type 2 diabetes mellitus and hypercholesterolemia to maintain cardiovascular health and to reduce the cardiovascular risk profile. As for isolated hypercholesterolemia, patients with diabetic dyslipoproteinemia should follow dietary recommendations to reduce the dietary intake of artificial trans fatty acids as well as saturated fatty acids by increasing the dietary intake of monounsaturated and polyunsaturated fatty acids. Due to the very high cardiovascular risk of persons with diabetic dyslipoproteinemia as well as suboptimal adherence and insufficient effectiveness of life style modifications, a nutritional therapy cannot replace pharmacological interventions.

Keywords

Coronary heart disease Dietary fat Diet modification Treatment adherence and compliance Therapeutic target values 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

C. Dawczynski gibt an, dass kein Interessenkonflikt besteht. S. Lorkowski weist darauf hin, dass er für Vorträge im Rahmen ärztlicher Fortbildungen von pharmazeutischen Unternehmen Honorare erhält.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien

Literatur

  1. 1.
    Abdelhamid AS, Martin N, Bridges C, Brainard JS, Wang X, Brown TJ, Hanson S, Jimoh OF, Ajabnoor SM, Deane KH, Song F, Hooper L (2018) Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD012345.pub2 CrossRefPubMedGoogle Scholar
  2. 2.
    American Diabetes Association (2018a) 9. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care 41(Suppl 1):S86–S104CrossRefGoogle Scholar
  3. 3.
    American Diabetes Association (2018b) 4. Lifestyle management: standards of medical care in diabetes-2018. Diabetes Care 41(Suppl 1):S38–S50CrossRefGoogle Scholar
  4. 4.
    American Diabetes Association (2018) 7. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2018. Diabetes Care 41(Suppl 1):S65–S72CrossRefGoogle Scholar
  5. 5.
    Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97(3):505–516CrossRefGoogle Scholar
  6. 6.
    Arnold N (2005) Compliance von Diabetikern – Eine Analyse von Einflussfaktoren anhand einer bevölkerungsbasierten Studie. Ludwig-Maximilians-Universität, München (Dissertation)Google Scholar
  7. 7.
    Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, Chew EY, Bosch J, Collins R, Lewington S, Armitage J, Clarke R, Omega-3 Treatment Trialists’ Collaboration (2018) Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol 3(3):225–234CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Azadbakht L, Fard NRP, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, Esmaillzadeh A, Willett WC (2011) Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care 34(1):55–57CrossRefGoogle Scholar
  9. 9.
    Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Miller M, Tardif JC et al; IT Investigators (2017) Rationale and design of REDUCE-IT: reduction of cardiovascular events with Icosapent ethyl-intervention trial. Clin Cardiol 40(3):138–148Google Scholar
  10. 10.
    Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB et al; REDUCE-IT Investigators (2018) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med.  https://doi.org/10.1056/NEJMoa1812792 CrossRefGoogle Scholar
  11. 11.
    Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT, ESC Scientific Document Group (2016) 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37(39):2999–3058CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 160(6):398–406.CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Clifton PM, Keogh JB (2017) A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease. Nutr Metab Cardiovasc Dis 27(12):1060–1080CrossRefGoogle Scholar
  14. 14.
    D-A-CH (Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (2017) Referenzwerte für die Nährstoffzufuhr, 2. Aufl., Deutsche Gesellschaft für Ernährung e.V., Bonn Google Scholar
  15. 15.
    Dawczynski C, Kleber ME, März W, Jahreis G, Lorkowski S (2015) Saturated fatty acids are not off the hook. Nutr Metab Cardiovasc Dis 25(12):1071–1078CrossRefGoogle Scholar
  16. 16.
    Dawczynski C, Schneider AC, Hartmann J, Lorkowski S (2017) Einfluss einer Ernährungsumstellung auf kardiovaskuläre Risikofaktoren – Ernährungsstudie MoKaRi. Proceedings of the German Nutrition Society. 23:29. Die Veröffentlichung der MoKaRi-Studie in einer internationalen Fachzeitschrift ist in Vorbereitung. Google Scholar
  17. 17.
    de Oliveira OMC, Wu JH, Baylin A, Vaidya D, Rich SS, Tsai MY, Jacobs DR Jr, Mozaffarian D (2013) Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2(6):e506Google Scholar
  18. 18.
    de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, Uleryk E, Budylowski P, Schünemann H, Beyene J, Anand SS (2015) Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 351:h3978CrossRefPubMedCentralGoogle Scholar
  19. 19.
    de Souza RJ, Anand SS (2016) Saturated fat and heart disease. BMJ 355:i6257CrossRefGoogle Scholar
  20. 20.
    DGE (2015) Evidenzbasierte Leitlinie: Fettzufuhr und Prävention ausgewählter ernährungsmitbedingter Krankheiten (2. Version)Google Scholar
  21. 21.
    Esposito K, Maiorino MI, Ciotola M, Di Palo C, Scognamiglio P, Gicchino M, Petrizzo M, Saccomanno F, Beneduce F, Ceriello A, Giugliano D (2009) Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 151(5):306–314CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Esposito K, Maiorino MI, Petrizzo M, Bellastella G, Giugliano D (2014) The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial. Diabetes Care 37(7):1824–1830CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Estruch R, Ros E (2017) Nutrition intervention on cardiovascular risk factors in healthy individuals: glass half empty or half full? J Am Coll Cardiol 69(9):1113–1115CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Fitó M, Gea A, Hernán MA, Martínez-González MA, PREDIMED Study Investigators (2018) Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med 378(25):e34CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Eyres L, Eyres MF, Chisholm A, Brown RC (2016) Coconut oil consumption and cardiovascular risk factors in humans. Nutr Rev 74(4):267–280CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Fattore E, Bosetti C, Brighenti F, Agostoni C, Fattore G (2014) Palm oil and blood lipid-related markers of cardiovascular disease: a systematic review and meta-analysis of dietary intervention trials. Am J Clin Nutr 99(6):1331–1350CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38(32):2459–2472CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Fiebig HJ (2018) DGF: Fettsäurezusammensetzung wichtiger pflanzlicher und tierischer Speisefette und -öle. Fettsäurezusammensetzung wichtiger pflanzlicher und tierischer Speisefette und -öle. http://www.dgfett.de/material/fszus.php. Zugegriffen: 1. Nov. 2018Google Scholar
  29. 29.
    Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB (2009a) Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 119(8):1093–1100CrossRefPubMedCentralGoogle Scholar
  30. 30.
    Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB (2009b) Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr 89(4):1037–1042CrossRefPubMedCentralGoogle Scholar
  31. 31.
    Gaede P, Pedersen O (2004) Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis. Diabetes 53(Suppl 3):S39–S47CrossRefGoogle Scholar
  32. 32.
    Harcombe Z (2018) US dietary guidelines: is saturated fat a nutrient of concern? Br J Sports Med.  https://doi.org/10.1136/bjsports-2018-099420 CrossRefPubMedGoogle Scholar
  33. 33.
    Hartley L, May MD, Loveman E, Colquitt JL, Rees K (2016) Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD011472.pub2 CrossRefPubMedGoogle Scholar
  34. 34.
    Hooper L, Martin N, Abdelhamid A, Davey Smith G (2015) Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD011737 CrossRefPubMedGoogle Scholar
  35. 35.
    Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore HJ, Smith GD (2016) Reduced or modified dietary fat for preventing cardiovascular disease. Sao Paulo Med J 134(2):182–183CrossRefGoogle Scholar
  36. 36.
    Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM (2006) Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295(6):655–666CrossRefGoogle Scholar
  37. 37.
    Huang C, Huang J, Tian Y, Yang X, Gu D (2014) Sugar sweetened beverages consumption and risk of coronary heart disease: a meta-analysis of prospective studies. Atherosclerosis 234(1):11–16CrossRefGoogle Scholar
  38. 38.
    Huo R, Du T, Xu Y, Xu W, Chen X, Sun K, Yu X (2015) Effects of mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr 69(11):1200–1208CrossRefGoogle Scholar
  39. 39.
    Jakobsen MU, O’Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A (2009) Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 89(5):1425–1432CrossRefPubMedCentralGoogle Scholar
  40. 40.
    Jenkins DJA, Boucher BA, Ashbury FD, Sloan M, Brown P, El-Sohemy A, Hanley AJ, Willett W, Paquette M, de Souza RJ, Ireland C, Kwan N, Jenkins A, Pichika SC, Kreiger N (2017) Effect of current dietary recommendations on weight loss and cardiovascular risk factors. J Am Coll Cardiol 69(9):1103–1112CrossRefGoogle Scholar
  41. 41.
    Kleber ME, Delgado GE, Lorkowski S, März W, von Schacky C (2015) Trans fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study. Eur Heart J 37(13):1072–1078CrossRefGoogle Scholar
  42. 42.
    Klostermann R (2014) Die „Fett-Revolution“: Tierische Fette sind doch nicht schädlich fürs Herz! BILD Thüringen, 21. März 2014. http://www.bild.de/ratgeber/gesundheit/fette/tierisches-fett-doch-besser-als-pflanzliches-studie-35156914.bild.html. Zugegriffen: 4. Nov. 2018 Google Scholar
  43. 43.
    Kotseva K, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, Abreu A, Aguiar C, Conde AC, Davletov K, Dilic M, Dolzhenko M, Gaita D, Georgiev B, Gotcheva N, Lalic N, Laucevicius A, Lovic D, Mancas S, Miličić D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Vulic D, Wood D, The Euroaspire Investigators (2016) Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol 23(18):2007–2018CrossRefGoogle Scholar
  44. 44.
    Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B (2012) Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 5(6):808–818CrossRefGoogle Scholar
  45. 45.
    Lawson RE, Moss AR, Givens DI (2001) The role of dairy products in supplying conjugated linoleic acid to man’s diet: a review. Nutr Res Rev 14(1):153–172CrossRefGoogle Scholar
  46. 46.
    Li Y, Hruby A, Bernstein AM, Ley SH, Wang DD, Chiuve SE et al (2015) Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study. J Am Coll Cardiol 66(14):1538–1548CrossRefPubMedCentralGoogle Scholar
  47. 47.
    Lin JS, O’Connor E, Evans CV, Senger CA, Rowland MG, Groom HC (2014) Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 161(8):568–578CrossRefGoogle Scholar
  48. 48.
    Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, Fung TT, Li S, Willett WC, Rimm EB, Hu FB (2014) The Mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease. Am J Clin Nutr 99(1):172–180CrossRefGoogle Scholar
  49. 49.
    März W, Dippel FW, Theobald K, Gorcyca K, Iorga ŞR, Ansell D (2018) Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: real-world evidence from Germany. Atherosclerosis 268:99–107CrossRefGoogle Scholar
  50. 50.
    Maki KC, Palacios OM, Bell M, Toth PP (2017) Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: an updated meta-analysis and review of research gaps. J Clin Lipidol 11(5):1152–1160CrossRefPubMedCentralGoogle Scholar
  51. 51.
    Mente A, de Koning L, Shannon HS, Anand SS (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169(7):659–669CrossRefPubMedCentralGoogle Scholar
  52. 52.
    Michas G, Micha R, Zampelas A (2014) Dietary fats and cardiovascular disease: putting together the pieces of a complicated puzzle. Atherosclerosis 234(2):320–328CrossRefPubMedCentralGoogle Scholar
  53. 53.
    Mozaffarian D, Micha R, Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. Plos Med 7:e1000252CrossRefPubMedCentralGoogle Scholar
  54. 54.
    Mozaffarian D, Wu JH (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58(20):2047–2067CrossRefPubMedCentralGoogle Scholar
  55. 55.
    Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS (2013) Plasma phospholipid long-chain ω‑3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 158(7):515–525CrossRefPubMedCentralGoogle Scholar
  56. 56.
    Pankofer R, Schandry R (1994) Krankheitskonzept und Complianceverhalten bei Asthma- und Bronchitis-Patienten. Verhaltensmodif Verhaltensmed 15(2):126–140Google Scholar
  57. 57.
    Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308:1024–1033CrossRefGoogle Scholar
  58. 58.
    Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ, Dietary Intervention Randomized Controlled Trial (DIRECT) Group (2008) Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359(3):229–241CrossRefGoogle Scholar
  59. 59.
    Snorgaard O, Poulsen GM, Andersen HK, Astrup A (2017) Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care 5(1):e354CrossRefPubMedCentralGoogle Scholar
  60. 60.
    Sun Y, Neelakantan N, Wu Y, Lote-Oke R, Pan A, van Dam RM (2015) Palm Oil Consumption increases LDL cholesterol compared with vegetable oils low in saturated fat in a meta-analysis of clinical trials. J Nutr 145(7):1549–1558CrossRefPubMedCentralGoogle Scholar
  61. 61.
    Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ (2013) Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 347:f6879CrossRefPubMedCentralGoogle Scholar
  62. 62.
    Vos MB, Kaar JL, Welsh JA, Van Horn LV, Feig DI, Anderson CAM, Patel MJ, Munos CJ, Krebs NF, Xanthakos SA, Johnson RK, American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Functional Genomics and Translational Biology, Council on Hypertension (2017) Added sugars and cardiovascular disease risk in children: a scientific statement from the American Heart Association. Circulation 135(19):e1017–e1034CrossRefPubMedCentralGoogle Scholar
  63. 63.
    Wang DD, Li Y, Chiuve SE, Stampfer MJ, Manson JE, Rimm EB, Willett WC, Hu FB (2016) Association of specific dietary fats with total and cause-specific mortality. JAMA Intern Med 176(8):1134–1145CrossRefPubMedCentralGoogle Scholar
  64. 64.
    Wilke T (2011) Nicht-Adhärenz von Patienten und Adhärenz-Programme. Dtsch Apothekerz 28:63–67Google Scholar
  65. 65.
    Wolfram G, Bechthold A, Boeing H, Ellinger S, Hauner H, Kroke A, Leschik-Bonnet E, Lin-seisen J, Lorkowski S, Schulze M, Stehle P, Dinter J (2015) Evidence-based guideline of the German Nutrition Society: fat intake and prevention of selected nutrition-related diseases. Ann Nutr Metab 67(3):141–204CrossRefPubMedCentralGoogle Scholar
  66. 66.
    Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB (2014) Added sugar intake and cardiovascular diseases mortality among US adults. Jama Intern Med 174(4):516–524CrossRefPubMedCentralGoogle Scholar
  67. 67.
    Yokoyama Y, Barnard ND, Levin SM, Watanabe M (2014) Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovasc Diagn Ther 4(5):373–382PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Institut für Ernährungswissenschaften und Kompetenzcluster für Ernährung und kardiovaskuläre Gesundheit (nutriCARD), Halle-Jena-LeipzigFriedrich-Schiller-Universität JenaJenaDeutschland

Personalised recommendations